Skip to main content
Erschienen in: Annals of Surgical Oncology 2/2020

19.09.2019 | Head and Neck Oncology

Predictors and Prevalence of Nodal Disease in Salvage Oropharyngectomy

verfasst von: M. E. Heft Neal, MD, J. Brennan, MD, J. C. Brenner, PhD, A. G. Shuman, MD, S. B. Chinn, MD, C. L. Stucken, MD, K. M. Malloy, MD, J. S. Moyer, MD, K. A. Casper, MD, S. A. McLean, MD, M. E. P. Prince, MD, C. R. Bradford, MD, G. T. Wolf, MD, D. B. Chepeha, MD, A. J. Rosko, MD, M. E. Spector, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Patients with recurrent oropharyngeal cancer often require extensive salvage surgery. For patients with clinically N0 necks, the indication for concurrent neck dissection remains unclear. This study aimed to determine predictors, prevalence, and distribution of nodal disease in patients treated with salvage oropharyngectomy.

Methods

In a case series with data collection at a single tertiary academic National Cancer Institute (NCI)-designated comprehensive cancer center, this study analyzed patients treated with prior radiation or chemoradiation who had persistent, recurrent, or second primary squamous cell carcinoma of the oropharynx requiring oropharyngeal resection between 1998 and 2017 (n = 95). Clinical and oncologic characteristics and treatment outcomes were collected, and statistical analyses were performed.

Results

The overall rate of nodal positivity was 21% (24/95), and the rate of occult nodal disease was 6% (4/65). Ipsilateral and contralateral level 2 were the most common areas harboring positive nodes. Bivariate analysis showed female sex (p = 0.01), initial overall stage (p = 0.02), and N status (p = 0.03), as well as recurrent overall and T stage (p = 0.05) to be predictors of nodal disease. In the multivariate analysis, recurrent T stage continued to be significantly predictive of pathologic nodal disease. Both computed tomography (CT) and positron emission tomography–CT were moderately accurate in predicting nodal disease in the salvage setting (area under the curve, 0.79 and 0.80, respectively).

Conclusion

Occult nodal disease is observed in few patients undergoing salvage oropharyngeal resection. This study identified factors predictive of nodal disease in patients undergoing salvage oropharyngectomy and appropriate diagnostic tests in this setting.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer. 2007;110:1429–35.CrossRef Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer. 2007;110:1429–35.CrossRef
2.
Zurück zum Zitat Pytynia KB, Dahlstrom KR, Sturgis EM. Epidemiology of HPV-associated oropharyngeal cancer. Oral Oncol. 2014;50:380–6.CrossRef Pytynia KB, Dahlstrom KR, Sturgis EM. Epidemiology of HPV-associated oropharyngeal cancer. Oral Oncol. 2014;50:380–6.CrossRef
3.
Zurück zum Zitat Haughey BH, Sinha P. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer. Laryngoscope. 2012;122(Suppl 2):S13–33.CrossRef Haughey BH, Sinha P. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer. Laryngoscope. 2012;122(Suppl 2):S13–33.CrossRef
4.
Zurück zum Zitat Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol. 2009;27:1992–8.CrossRef Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol. 2009;27:1992–8.CrossRef
5.
Zurück zum Zitat Taneja C, Allen H, Koness RJ, Radie-Keane K, Wanebo HJ. Changing patterns of failure of head and neck cancer. Arch Otolaryngol Head Neck Surg. 2002;128:324–7.CrossRef Taneja C, Allen H, Koness RJ, Radie-Keane K, Wanebo HJ. Changing patterns of failure of head and neck cancer. Arch Otolaryngol Head Neck Surg. 2002;128:324–7.CrossRef
6.
Zurück zum Zitat Zafereo ME, Hanasono MM, Rosenthal DI, et al. The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx. Cancer. 2009;115:5723–33.CrossRef Zafereo ME, Hanasono MM, Rosenthal DI, et al. The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx. Cancer. 2009;115:5723–33.CrossRef
7.
Zurück zum Zitat Da Mosto MC, Zanetti F, Boscolo-Rizzo P. Pattern of lymph node metastases in squamous cell carcinoma of the tonsil: implication for selective neck dissection. Oral Oncol. 2009;45:212–7.CrossRef Da Mosto MC, Zanetti F, Boscolo-Rizzo P. Pattern of lymph node metastases in squamous cell carcinoma of the tonsil: implication for selective neck dissection. Oral Oncol. 2009;45:212–7.CrossRef
8.
Zurück zum Zitat Gross BC, Olsen SM, Lewis JE, et al. Level IIB lymph node metastasis in oropharyngeal squamous cell carcinoma. Laryngoscope. 2013;123:2700–5.CrossRef Gross BC, Olsen SM, Lewis JE, et al. Level IIB lymph node metastasis in oropharyngeal squamous cell carcinoma. Laryngoscope. 2013;123:2700–5.CrossRef
9.
Zurück zum Zitat Jose J, Coatesworth AP, Johnston C, MacLennan K. Cervical node metastases in oropharyngeal squamous cell carcinoma: prospective analysis of prevalence and distribution. J Laryngol Otol. 2002;116:925–8.CrossRef Jose J, Coatesworth AP, Johnston C, MacLennan K. Cervical node metastases in oropharyngeal squamous cell carcinoma: prospective analysis of prevalence and distribution. J Laryngol Otol. 2002;116:925–8.CrossRef
10.
Zurück zum Zitat Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer. 1972;29:1446–9.CrossRef Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer. 1972;29:1446–9.CrossRef
11.
Zurück zum Zitat Shah JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg. 1990;160:405–9.CrossRef Shah JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg. 1990;160:405–9.CrossRef
12.
Zurück zum Zitat Shimizu K, Inoue H, Saitoh M, et al. Distribution and impact of lymph node metastases in oropharyngeal cancer. Acta Otolaryngol. 2006;126:872–7.CrossRef Shimizu K, Inoue H, Saitoh M, et al. Distribution and impact of lymph node metastases in oropharyngeal cancer. Acta Otolaryngol. 2006;126:872–7.CrossRef
13.
Zurück zum Zitat Vartanian JG, Pontes E, Agra IM, et al. Distribution of metastatic lymph nodes in oropharyngeal carcinoma and its implications for the elective treatment of the neck. Arch Otolaryngol Head Neck Surg. 2003;129:729–32.CrossRef Vartanian JG, Pontes E, Agra IM, et al. Distribution of metastatic lymph nodes in oropharyngeal carcinoma and its implications for the elective treatment of the neck. Arch Otolaryngol Head Neck Surg. 2003;129:729–32.CrossRef
14.
Zurück zum Zitat Falchook AD, Dagan R, Morris CG, Mendenhall WM. Elective neck dissection for second primary after previous definitive radiotherapy. Am J Otolaryngol. 2012;33:199–204.CrossRef Falchook AD, Dagan R, Morris CG, Mendenhall WM. Elective neck dissection for second primary after previous definitive radiotherapy. Am J Otolaryngol. 2012;33:199–204.CrossRef
15.
Zurück zum Zitat Birkeland AC, Rosko AJ, Issa MR, et al. Occult nodal disease prevalence and distribution in recurrent laryngeal cancer requiring salvage laryngectomy. Otolaryngol Head Neck Surg. 2016;154:473–9.CrossRef Birkeland AC, Rosko AJ, Issa MR, et al. Occult nodal disease prevalence and distribution in recurrent laryngeal cancer requiring salvage laryngectomy. Otolaryngol Head Neck Surg. 2016;154:473–9.CrossRef
16.
Zurück zum Zitat Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–4.CrossRef Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–4.CrossRef
17.
Zurück zum Zitat Adams S, Baum RP, Stuckensen T, Bitter K, Hor G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nuclear Med. 1998;25:1255–60.CrossRef Adams S, Baum RP, Stuckensen T, Bitter K, Hor G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nuclear Med. 1998;25:1255–60.CrossRef
18.
Zurück zum Zitat Martin H. The case for prophylactic neck dissection, 1951. CA Cancer J Clin. 1990;40:245–51.CrossRef Martin H. The case for prophylactic neck dissection, 1951. CA Cancer J Clin. 1990;40:245–51.CrossRef
19.
Zurück zum Zitat Robbins KT. Indications for selective neck dissection: when, how, and why. Oncology. 2000;14:1455–64; discussion 1467–1459.PubMed Robbins KT. Indications for selective neck dissection: when, how, and why. Oncology. 2000;14:1455–64; discussion 1467–1459.PubMed
20.
Zurück zum Zitat Weiss MH, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surge. 1994;120:699–702.CrossRef Weiss MH, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surge. 1994;120:699–702.CrossRef
21.
Zurück zum Zitat Ferlito A, Shaha AR, Rinaldo A. The incidence of lymph node micrometastases in patients pathologically staged N0 in cancer of oral cavity and oropharynx. Oral Oncol. 2002;38:3–5.CrossRef Ferlito A, Shaha AR, Rinaldo A. The incidence of lymph node micrometastases in patients pathologically staged N0 in cancer of oral cavity and oropharynx. Oral Oncol. 2002;38:3–5.CrossRef
22.
Zurück zum Zitat Kato MG, Ellis MA, Nguyen SA, Day TA. Predictors of contralateral–bilateral nodal disease in oropharyngeal cancer: a National Cancer Data Base Study. Head Neck. 2018;40:338–48.CrossRef Kato MG, Ellis MA, Nguyen SA, Day TA. Predictors of contralateral–bilateral nodal disease in oropharyngeal cancer: a National Cancer Data Base Study. Head Neck. 2018;40:338–48.CrossRef
23.
Zurück zum Zitat Tritter AG, Mehta V, Samuelson M, et al. Incidence of contralateral–bilateral nodes in the human papillomavirus era. Laryngoscope. 2017;127:1328–33.CrossRef Tritter AG, Mehta V, Samuelson M, et al. Incidence of contralateral–bilateral nodes in the human papillomavirus era. Laryngoscope. 2017;127:1328–33.CrossRef
24.
Zurück zum Zitat Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-d-glucose PET and MR imaging diagnoses. Radiology. 1996;200:135–41.CrossRef Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-d-glucose PET and MR imaging diagnoses. Radiology. 1996;200:135–41.CrossRef
25.
Zurück zum Zitat Hermans R. Posttreatment imaging in head and neck cancer. Eur J Radiol. 2008;66:501–11.CrossRef Hermans R. Posttreatment imaging in head and neck cancer. Eur J Radiol. 2008;66:501–11.CrossRef
26.
Zurück zum Zitat Gordin A, Golz A, Keidar Z, Daitzchman M, Bar-Shalom R, Israel O. The role of FDG-PET/CT imaging in head and neck malignant conditions: impact on diagnostic accuracy and patient care. Otolaryngol Head Neck Surg. 2007;137:130–7.CrossRef Gordin A, Golz A, Keidar Z, Daitzchman M, Bar-Shalom R, Israel O. The role of FDG-PET/CT imaging in head and neck malignant conditions: impact on diagnostic accuracy and patient care. Otolaryngol Head Neck Surg. 2007;137:130–7.CrossRef
27.
Zurück zum Zitat Murakami R, Uozumi H, Hirai T, et al. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2007;68:377–82.CrossRef Murakami R, Uozumi H, Hirai T, et al. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2007;68:377–82.CrossRef
28.
Zurück zum Zitat Ozer E, Naiboglu B, Meacham R, Ryoo C, Agrawal A, Schuller DE. The value of PET/CT to assess clinically negative necks. Eur Arch Otorhinolaryngol. 2012;269:2411–4.CrossRef Ozer E, Naiboglu B, Meacham R, Ryoo C, Agrawal A, Schuller DE. The value of PET/CT to assess clinically negative necks. Eur Arch Otorhinolaryngol. 2012;269:2411–4.CrossRef
29.
Zurück zum Zitat Schwartz DL, Ford E, Rajendran J,et al. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2005;61:129–36.CrossRef Schwartz DL, Ford E, Rajendran J,et al. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2005;61:129–36.CrossRef
30.
Zurück zum Zitat Nahmias C, Carlson ER, Duncan LD, et al. Positron emission tomography/computerized tomography (PET/CT) scanning for preoperative staging of patients with oral/head and neck cancer. J Oral Maxillofac Surg. 2007;65:2524–35.CrossRef Nahmias C, Carlson ER, Duncan LD, et al. Positron emission tomography/computerized tomography (PET/CT) scanning for preoperative staging of patients with oral/head and neck cancer. J Oral Maxillofac Surg. 2007;65:2524–35.CrossRef
31.
Zurück zum Zitat Schoder H, Carlson DL, Kraus DH, et al. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nuclear Med. 2006;47:755–62. Schoder H, Carlson DL, Kraus DH, et al. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nuclear Med. 2006;47:755–62.
32.
Zurück zum Zitat Rosko A, Birkeland A, Shuman A, et al. Positron emission tomography-CT prediction of occult nodal metastasis in recurrent laryngeal cancer. Head Neck. 2017;39:980–7.CrossRef Rosko A, Birkeland A, Shuman A, et al. Positron emission tomography-CT prediction of occult nodal metastasis in recurrent laryngeal cancer. Head Neck. 2017;39:980–7.CrossRef
Metadaten
Titel
Predictors and Prevalence of Nodal Disease in Salvage Oropharyngectomy
verfasst von
M. E. Heft Neal, MD
J. Brennan, MD
J. C. Brenner, PhD
A. G. Shuman, MD
S. B. Chinn, MD
C. L. Stucken, MD
K. M. Malloy, MD
J. S. Moyer, MD
K. A. Casper, MD
S. A. McLean, MD
M. E. P. Prince, MD
C. R. Bradford, MD
G. T. Wolf, MD
D. B. Chepeha, MD
A. J. Rosko, MD
M. E. Spector, MD
Publikationsdatum
19.09.2019
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 2/2020
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07841-7

Weitere Artikel der Ausgabe 2/2020

Annals of Surgical Oncology 2/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.